Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial

Background: Ubiquitous digital technologies such as smartphone sensors promise to fundamentally change biomedical research and treatment monitoring in neurological diseases such as PD, creating a new domain of digital biomarkers. Objectives: The present study assessed the feasibility, reliability, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipsmeier, Florian, Taylor, Kirsten I., Kilchenmann, Timothy, Wolf, Detlef, Scotland, Alf, Schjodt‐Eriksen, Jens, Cheng, Wei‐Yi, Fernandez‐Garcia, Ignacio, Siebourg‐Polster, Juliane, Jin, Liping, Soto, Jay, Verselis, Lynne, Boess, Frank, Koller, Martin, Grundman, Michael, Monsch, Andreas U., Postuma, Ronald B., Ghosh, Anirvan, Kremer, Thomas, Czech, Christian, Gossens, Christian, Lindemann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175318/
https://www.ncbi.nlm.nih.gov/pubmed/29701258
http://dx.doi.org/10.1002/mds.27376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175318/
https://www.ncbi.nlm.nih.gov/pubmed/29701258
http://dx.doi.org/10.1002/mds.27376

Ejemplares similares